What is Giant Biogene Holding Co Operating Cash Flow per Share?
Giant Biogene Holding Co's operating cash flow per share for the
six
months ended in Dec. 2023 was HK$1.09.
Giant Biogene Holding Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.84.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Giant Biogene Holding Co was 80.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 22.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Giant Biogene Holding Co's Operating Cash Flow per Share or its related term are showing as below:
HKSE:02367'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 11.4 Med: 16.95 Max: 22.5
Current: 22.5
During the past 5 years, Giant Biogene Holding Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 22.50% per year. The lowest was 11.40% per year. And the median was 16.95% per year.
HKSE:02367's 3-Year OCF Growth Rate is ranked better than 73.54% of 1406
companies
in the Consumer Packaged Goods industry
Industry Median: 4.1
vs HKSE:02367: 22.50
Giant Biogene Holding Co Operating Cash Flow per Share Historical Data
The historical data trend for Giant Biogene Holding Co's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Giant Biogene Holding Co Operating Cash Flow per Share Chart
Competitive Comparison of Giant Biogene Holding Co's Operating Cash Flow per Share
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co's Price-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Price-to-Operating-Cash-Flow falls into.
Giant Biogene Holding Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Giant Biogene Holding Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.84
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Giant Biogene Holding Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Giant Biogene Holding Co (HKSE:02367) Business Description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02367 has been successfully added to your